United States · Investor

Affinity Capital Management

Last cheque observed May 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firmWebsite unconfirmed

GrowthPre-seedSeedConsumerFinance & CryptoSoftware & Internet

Cheques on record
0%of best year0cheques in 12 months, 26 on record
Since the last cheque5277days00hrs00min00sec
Median round$20MRounds led0 of 26Sole investor1 roundsExits6 from the portfolioMostly inUnited States, 100%
Pitch Affinity Capital Management

Affinity Capital Management highlights

  1. 01

    26 rounds on record

  2. 02

    Mostly Series C and Series B: 52% of its rounds

  3. 03

    Sole investor in 1 rounds, median $1.5M

  4. 04

    6 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
GrowthPre-seedSeedSeries ASeries B
Sectors
ConsumerFinance & CryptoSoftware & Internet
Based in
United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first26 appearances

  1. 2012

    3 rounds

  2. May
    Sonitus MedicalSeries D · US · sonitusmedical.com$25MWith 5 others
  3. Mar
    Uptake MedicalSeries C · US · sec.gov$40MWith 6 others
  4. Jan
    iScience InterventionalVenture · US · researchviews.com$2.8MWith 5 others
  5. 2010

    4 rounds

  6. Jul
    Uptake MedicalSeries B · US · uptakemedical.com$18MWith 5 others
  7. Jun
    BaxanoSeries C · US · onbiovc.com$30MWith 5 others
  8. Jun
    AnulexSeries E · US · onbiovc.com$18MWith 3 others
  9. Apr
    HemosphereSeries A · US · onbiovc.com$9.3MWith 6 others
  10. 2009

    4 rounds

  11. Oct
    ValenTxSeries B · US · onbiovc.com$20MWith 5 others
  12. Jun
    CoAxiaSeries D · US · onbiovc.com$22MWith 5 others
  13. May
    iScience InterventionalSeries F · US · onbiovc.com$21MWith 7 others
  14. Feb
    Primaeva MedicalSeries C · US · deals.venturebeat.com$6.0MWith 2 others
  15. 2008

    4 rounds

  16. Oct
    Cardiac ConceptsSeries B · US · equityhelpdesk.com$21MWith 5 others
  17. Aug
    SpineologySeries B$1.5MSole investor
  18. May
    NovaSysVenture · US · deals.venturebeat.com$50MWith 10 others
  19. Jan
    Arbor Surgical TechnologiesSeries C · US$20MWith 10 others
  20. 2007

    3 rounds

  21. Sept
    AtritechSeries D · US$22MWith 5 others
  22. May
    Pegasus BiologicsSeries C · US$20MWith 3 others
  23. Mar
    Transoma MedicalSeries C · US$13MWith 2 others
  24. 2006

    2 rounds

  25. Sept
    CoAxiaSeries C · US$11MWith 3 others
  26. Jul
    AnulexSeries C · US · businesswire.com$20MWith 5 others
  27. 2004

    3 rounds

  28. Dec
    MyocorSeries D · US$24MWith 7 others
  29. May
    Disc DynamicsVenture · US$24MWith 3 others
  30. Apr
    NOVASYS MEDICALSeries C · US$25MWith 6 others
  31. 2002

    2 rounds

  32. Dec
    QuickMedxSeries A · US$2.7MWith 2 others
  33. Nov
    Alliance Medical CorporationSeries E · US$7.3MWith 5 others
  34. 2000

    1 round

  35. Aug
    IcanVenture · US$4.0MWith 3 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

BaxanoBought by TranS1UndisclosedMar 2013
HemosphereBought by CryoLife$22MMay 2012
AtritechBought by Boston Scientific$375MJan 2011
Primaeva MedicalBought by Syneron Medical$30MOct 2009
Pegasus BiologicsBought by Synovis Life Technologies$12MJul 2009
MyocorBought by Edwards LifesciencesUndisclosedOct 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Affinity Capital Management. A count of rooms they were both in, not a relationship either has claimed.

Delphi VenturesVC firm8rounds togetherThree Arch PartnersGrowth equity8rounds togetherONSET VenturesVC firm5rounds togetherGBS VenturesVC firm4rounds togetherJohnson & Johnson Development Corporation (JJDC)VC firm4rounds togetherKaiser Permanente VenturesCorporate VC4rounds togetherAlloy VenturesVC firm3rounds togetherArboretum VenturesVC firm3rounds togetherCanaanVC firm3rounds togetherSapient FundInvestment firm3rounds togetherBaird CapitalWealth manager2rounds togetherCoral VenturesVC firm2rounds together

Quick answers about Affinity Capital Management

What does Affinity Capital Management invest in?

Affinity Capital Management invests most often at Series C and Series B (52% of the rounds on record), in sectors such as Consumer, Finance & Crypto and Software & Internet.

How active is Affinity Capital Management?

26 investments on record, 0 of them in the last 12 months. The most recent was in May 2012.

How big are Affinity Capital Management's cheques?

The median round it joins is $20M.

Does Affinity Capital Management lead rounds?

Rarely, if at all: none of its 26 investments on record names it as the lead.

Where does Affinity Capital Management invest?

Most of the companies it backs are in the United States (100%).

Is Affinity Capital Management investing now?

No investments in the last 12 months; the latest was in May 2012.

Who does Affinity Capital Management invest alongside?

Most often Delphi Ventures (8 rounds together), Three Arch Partners (8 rounds together) and ONSET Ventures (5 rounds together).

What kind of investor is Affinity Capital Management?

Affinity Capital Management is a VC firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it